U.S. FDA warns against heart inflammation risk from Novavax COVID-19 vaccine - Global News
6/3/2022 12:00:00 AM2 years 11 months ago
by Reuters
by Reuters
The U.S. Food and Drug Administration has raised concerns about a possible risk of heart inflammation from Novavax Inc's NVAX.OCOVID-19 vaccine.
The U.S. Food and Drug Administration has raised concerns about a possible risk of heart inflammation from Novavax Inc’s NVAX.OCOVID-19 vaccine, even as the company’s data showed it could reduce the … [+2811 chars]
full article...